slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,391-3,420
Pages 202
Rows per page 30
Slide function
3,391-3,420 of 6,044
47
The slide uses a growth curve to illustrate technological progression over time.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a pipeline table format to show the progression of various drug candidates (SPY001-SPY230) across discovery, IND-enabling, and clinical stages.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Golden Circle1 hit
13
The slide uses a Gantt-style visualization to show the progress of various drug candidates (SPY001-SPY230).Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
The slide uses a Gantt-style visualization to show the status of various drug development programs.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
30
The slide uses a table-like layout to represent a drug development pipeline.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
38
The slide uses a matrix-like layout to map targets and programs against development stages.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Evidence1 hit
42
The slide uses a timeline-based process diagram to illustrate the clinical trial strategy.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Evidence1 hit
48
The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
06
The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
09
The slide uses a 3D-like coordinate system to represent growth vectors.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
03
The slide uses a Gantt-style chart to map product development stages from pre-clinical to FDA approval.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
17
The slide uses a funnel-like diagram to represent the patient recruitment and study flow.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
25
Focuses on regulatory strategy and clinical trial design parameters for Phase 3.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
17
The slide uses a visual progression path (stepping stones) to show the journey from current state to future target.Essity | Results Presentation Deck | 19 slides · Essity
Conference presentation Investor relations Beat · Road to ROCE Target1 hit
25
Eutelsat | Results Presentation Deck | 28 slidesEutelsat | Results Presentation Deck | 28 slides · Eutelsat
Conference presentation Investor relations Beat · Why NowLoop · Cost Of Inaction1 hit
04
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations 1 hit
07
The chart uses a horizontal bar format to represent development stages.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a stepped arrow diagram to represent progress over time, categorized into three phases of target difficulty.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
30
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a specific focus on biomarker-driven patient selection.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
37
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
32
Uses a custom timeline layout with color-coded bars to indicate the nature of the investment.First Busey | Results Presentation Deck | 41 slides · First Busey Corporation
Deck Investor relations Loop · Golden Circle1 hit
03
Flushing Financial | Results Presentation Deck | 37 slidesFlushing Financial | Results Presentation Deck | 37 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · Need1 hit
05
The slide uses a Gantt-style visualization to map drug development progress against clinical phases.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
18
The slide outlines a randomized, open-label trial comparing Olvi-Vec + Platinum-doublet + Bevacizumab against a standard comparator arm.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
The slide uses a hub-and-spoke style layout to show the four pillars supporting the central launch strategy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style visual for the 'Pre-clinical' stage, though it is not a full timeline.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a horizontal timeline with milestones mapped to specific quarters.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
18
The slide uses a hierarchical structure to show how core business investment leads to cash flow, which is then distributed across four pillars.Kenvue | Results Presentation Deck | 31 slides · Kenvue
Conference presentation Investor relations Beat · ActionLoop · Logic Chain1 hit
05
The slide features a stylized owl logo, which is the Kering corporate symbol.Kering | Results Presentation Deck | 42 slides · Kering
Conference presentation Investor relations Beat · Problem & Complication1 hit
27
Part of a financial strategy section in an investor presentation.Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · Financials1 hit